Figure 1.
Immunostaining of HOXA13 in vaginal specimens obtained from a patient with normal pelvic support with inlay of immunostaining with rabbit IgG as the negative control (1A.), a patient with normal pelvic support treated with leuprolide acetate (1B.), a premenopausal patient with POP (1C.) and a postmenopausal patient with POP (1D.) (magnification 60x)